In evaluating new healthcare interventions, how are economic evaluations typically used to inform policy decisions?

Prepare for the Business of Healthcare and Health Policy Test. Study with multiple choice questions and explanations to ace your exam!

Economic evaluations inform policy by comparing what a new healthcare intervention costs with the health benefits it produces relative to the current standard of care. The common metric is the incremental cost-effectiveness ratio (ICER), which is the additional cost divided by the additional health effect (often measured in QALYs or life-years gained). Policy decisions often rely on thresholds that reflect willingness to pay for an extra unit of health gain; if the ICER falls at or below the threshold, the intervention is considered cost-effective and more likely to be funded, whereas an ICER above the threshold suggests it may not be worth the extra cost unless prices or assumptions change or there are other compelling benefits. Remember that economic evaluations are one part of decision-making and should be considered alongside budget impact, feasibility, and equity considerations, not in isolation.